Ulrike Bremer

Title: Ulrike Bremer: Innovator in Transdermal Drug Delivery

Introduction

Ulrike Bremer is a notable inventor based in Menlo Park, CA (US). She has made significant contributions to the field of transdermal drug delivery, particularly in the development of alpha-adrenoceptor blocking agents. With a total of 2 patents to her name, her work has the potential to impact therapeutic practices significantly.

Latest Patents

Ulrike's latest patents focus on the transdermal administration of alpha-adrenoceptor blocking compounds. The first patent outlines methods for administering these compounds to patients in therapeutically effective amounts. The second patent introduces a transdermal patch designed for the delivery of a specific compound, referred to as Compound IV. This patch includes a backing layer, a drug depot containing Compound IV, and a permeation enhancer composition, which facilitates the effective delivery of the drug through the skin.

Career Highlights

Ulrike Bremer is currently associated with Flora Inc., where she continues to innovate in the field of drug delivery systems. Her work is characterized by a commitment to improving patient outcomes through advanced therapeutic methods.

Collaborations

Ulrike has collaborated with talented individuals such as Giancarlo Santus and Aeri Kim, who contribute to her innovative projects and research endeavors.

Conclusion

Ulrike Bremer's contributions to transdermal drug delivery exemplify the impact of innovation in healthcare. Her patents and ongoing work at Flora Inc. highlight her dedication to advancing medical technology for better patient care.